Structures by: Nayak P. S.
Total: 52
<i>N</i>-(4-Chloro-3-methylphenyl)-2-phenylacetamide
C15H14ClNO
Acta crystallographica. Section C, Structural chemistry (2014) 70, Pt 9 889-894
a=5.0039(7)Å b=10.7525(12)Å c=12.6177(12)Å
α=108.615(10)° β=91.771(11)° γ=90.167(11)°
<i>N</i>-(4-Chloro-3-methylphenyl)-2-(2,4-dichlorophenyl)acetamide
C15H12Cl3NO
Acta crystallographica. Section C, Structural chemistry (2014) 70, Pt 9 889-894
a=11.8441(7)Å b=4.7288(3)Å c=13.0981(7)Å
α=90° β=101.310(6)° γ=90°
<i>N</i>-(4-Bromo-3-methylphenyl)-2-(2-chlorophenyl)acetamide
C15H13BrClNO
Acta crystallographica. Section C, Structural chemistry (2014) 70, Pt 9 889-894
a=11.8458(8)Å b=4.7282(3)Å c=25.0757(15)Å
α=90° β=98.133(5)° γ=90°
(2<i>E</i>)-3-(6-Methoxynaphthalen-2-yl)-1-(pyridin-3-yl)prop-2-en-1-one
C19H15NO2
Acta Crystallographica Section C (2014) 70, 11 1011-1016
a=14.2636(6)Å b=16.6789(6)Å c=6.0084(2)Å
α=90° β=90° γ=90°
(<i>RS</i>)-2-Amino-4-(6-methoxynaphthalen-2-yl)-6-(pyridin-3-yl)-3,4-dihydropyrimidine monohydrate
C20H18N4O,H2O
Acta Crystallographica Section C (2014) 70, 11 1011-1016
a=17.2244(5)Å b=5.9552(2)Å c=18.5173(6)Å
α=90° β=112.8300(10)° γ=90°
2-(4-Chlorophenyl)-6-methoxychroman-4-one
C16H13ClO3
Acta Crystallographica Section E (2010) 66, 10 o2546-o2547
a=5.0188(3)Å b=12.0138(7)Å c=12.3708(7)Å
α=108.035(5)° β=98.379(4)° γ=91.820(5)°
(<i>E</i>)-3-(4-Methoxyphenyl)-1-[4-(piperidin-1-yl)phenyl]prop-2-en-1-one
C21H23NO2
Acta Crystallographica Section E (2010) 66, 8 o1996
a=6.0963(11)Å b=10.985(2)Å c=13.133(3)Å
α=74.188(3)° β=88.674(3)° γ=77.393(3)°
1-(10<i>H</i>-Phenothiazin-2-yl)ethanone
C14H11NOS
Acta Crystallographica Section E (2011) 67, 2 o430-o431
a=14.3445(18)Å b=5.5425(7)Å c=15.694(2)Å
α=90.00° β=114.494(2)° γ=90.00°
<i>N</i>-(4-Bromophenyl)-2-(naphthalen-1-yl)acetamide
C18H14BrNO
Acta Crystallographica Section E (2011) 67, 11 o2926-o2927
a=12.6837(11)Å b=9.4047(11)Å c=25.641(3)Å
α=90.00° β=90.00° γ=90.00°
(2<i>E</i>)-1-(2,5-Dimethoxyphenyl)-3-(3-nitrophenyl)prop-2-en-1-one
C17H15NO5
Acta Crystallographica Section E (2011) 67, 11 o3058-o3059
a=7.5015(5)Å b=7.9962(5)Å c=13.2468(8)Å
α=86.5070(10)° β=80.3420(10)° γ=76.3320(10)°
<i>N</i>-(3,5-Dichlorophenyl)-2-(naphthalen-1-yl)acetamide
C18H13Cl2NO
Acta Crystallographica Section E (2011) 67, 11 o2941-o2942
a=7.8090(14)Å b=24.811(4)Å c=9.6783(13)Å
α=90.00° β=125.050(10)° γ=90.00°
<i>N</i>-(4-Bromophenyl)-2-(4-chlorophenyl)acetamide
C14H11BrClNO
Acta Crystallographica Section E (2012) 68, 2 o519
a=15.584(8)Å b=4.763(3)Å c=18.139(10)Å
α=90.00° β=96.984(11)° γ=90.00°
(2<i>E</i>)-1-(3,4-Dichlorophenyl)-3-(2-hydroxyphenyl)prop-2-en-1-one
C15H10Cl2O2
Acta Crystallographica Section E (2012) 68, 2 o366
a=7.2551(6)Å b=7.8351(7)Å c=12.8049(11)Å
α=92.367(7)° β=102.946(8)° γ=109.011(8)°
2-(4-Bromophenyl)-<i>N</i>-(pyrazin-2-yl)acetamide
C12H10BrN3O
Acta Crystallographica Section E (2013) 69, 6 o891
a=10.6804(4)Å b=7.5196(3)Å c=29.1355(10)Å
α=90° β=90° γ=90°
<i>N</i>-(1,3-Benzothiazol-2-yl)acetamide
C9H8N2OS
Acta Crystallographica Section E (2013) 69, 11 o1622
a=11.1852(4)Å b=7.4037(4)Å c=20.9189(8)Å
α=90° β=94.408(3)° γ=90°
<i>N</i>-(2,4-Dimethylphenyl)-2,2-diphenylacetamide
C22H21NO
Acta Crystallographica Section E (2012) 68, 5 o1316-o1317
a=9.5520(9)Å b=10.2011(10)Å c=17.9656(17)Å
α=91.030(2)° β=98.957(2)° γ=90.377(2)°
2-(2,4-Dichlorophenyl)-<i>N</i>-(1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro- 1<i>H</i>-pyrazol-4-yl)acetamide
C19H17Cl2N3O2
Acta Crystallographica Section E (2013) 69, 1 o39
a=25.1853(5)Å b=8.18108(9)Å c=21.0978(4)Å
α=90.00° β=119.772(3)° γ=90.00°
4-(4-Iodoanilino)-2-methylene-4-oxobutanoic acid
C11H10INO3
Acta Crystallographica Section E (2013) 69, 1 o83
a=23.1111(6)Å b=4.78630(10)Å c=10.4262(2)Å
α=90.00° β=97.0710(10)° γ=90.00°
2-(2,6-Dichlorophenyl)-<i>N</i>-(1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro- 1<i>H</i>-pyrazol-4-yl)acetamide
C19H17Cl2N3O2
Acta Crystallographica Section E (2013) 69, 1 o46-o47
a=20.3442(11)Å b=12.1080(8)Å c=14.9500(8)Å
α=90.00° β=93.837(5)° γ=90.00°
4-[(<i>E</i>)-(4-Benzyloxybenzylidene)amino]-1,5-dimethyl-2-phenyl- 1<i>H</i>-pyrazol-3(2<i>H</i>)-one
C25H23N3O2
Acta Crystallographica Section E (2013) 69, 1 o115
a=13.0079(5)Å b=9.9079(4)Å c=17.0469(9)Å
α=90.00° β=103.674(4)° γ=90.00°
2-(2-Methylphenyl)-<i>N</i>-(1,3-thiazol-2-yl)acetamide
C12H12N2OS
Acta Crystallographica Section E (2014) 70, 6 o716
a=17.6983(6)Å b=4.94078(13)Å c=14.4603(5)Å
α=90° β=111.236(4)° γ=90°
4-[(4-Acetylphenyl)amino]-2-methylidene-4-oxobutanoic acid
C13H13NO4
Acta Crystallographica Section E (2014) 70, 7 o752-o753
a=5.0164(5)Å b=5.2908(4)Å c=21.8464(18)Å
α=92.833(6)° β=90.315(7)° γ=96.222(7)°
4-[(4-Bromophenyl)amino]-2-methylidene-4-oxobutanoic acid
C11H10BrNO3
Acta Crystallographica Section E (2014) 70, 7 o779-o780
a=6.2782(4)Å b=8.3251(5)Å c=21.3244(12)Å
α=96.462(5)° β=92.026(5)° γ=95.390(5)°
(2<i>E</i>)-3-(3-Nitrophenyl)-1-[4-(piperidin-1-yl)phenyl]prop-2-en-1-one
C20H20N2O3
Acta Crystallographica Section E (2012) 68, 4 o974
a=7.4268(12)Å b=11.3884(18)Å c=39.447(6)Å
α=90.00° β=90.00° γ=90.00°
<i>N</i>-(2,6-Dichlorophenyl)-2-(naphthalen-1-yl)acetamide
C18H13Cl2NO
Acta Crystallographica Section E (2012) 68, 5 o1385
a=13.1918(13)Å b=4.7199(5)Å c=24.878(2)Å
α=90.00° β=103.127(3)° γ=90.00°
<i>N</i>-(2,6-Dimethylphenyl)-2,2-diphenylacetamide
C22H21NO
Acta Crystallographica Section E (2012) 68, 5 o1287-o1288
a=12.0606(10)Å b=16.6747(13)Å c=8.9469(7)Å
α=90.00° β=108.080(2)° γ=90.00°
2,2-Diphenyl-<i>N</i>-(1,3-thiazol-2-yl)acetamide
C17H14N2OS
Acta Crystallographica Section E (2012) 68, 5 o1312-o1313
a=5.69150(10)Å b=15.1889(2)Å c=16.5967(2)Å
α=90.00° β=97.8450(10)° γ=90.00°
<i>N</i>-(3,4-Difluorophenyl)-2,2-diphenylacetamide
C20H15F2NO
Acta Crystallographica Section E (2012) 68, 5 o1349-o1350
a=9.9756(2)Å b=18.0181(3)Å c=9.8107(2)Å
α=90.00° β=117.0640(10)° γ=90.00°
<i>N</i>-(1,3-Thiazol-2-yl)-2-(2,4,6-trimethylphenyl)acetamide
C14H16N2OS
Acta Crystallographica Section E (2012) 68, 8 o2461
a=16.421(2)Å b=4.6397(7)Å c=20.1144(18)Å
α=90.00° β=123.150(7)° γ=90.00°
1-(3-Bromophenyl)thiourea
C7H7BrN2S
Acta Crystallographica Section E (2012) 68, 8 o2462
a=5.5308(8)Å b=8.5316(12)Å c=9.4249(14)Å
α=103.500(3)° β=90.878(3)° γ=97.232(4)°
<i>N</i>-(4-Chlorophenyl)-2-(naphthalen-1-yl)acetamide
C18H14ClNO
Acta Crystallographica Section E (2012) 68, 8 o2463
a=19.163(6)Å b=5.0458(11)Å c=17.252(4)Å
α=90.00° β=116.365(5)° γ=90.00°
2-(Naphthalen-1-yl)-<i>N</i>-(1,3-thiazol-2-yl)acetamide
C15H12N2OS
Acta Crystallographica Section E (2012) 68, 8 o2464
a=5.26680(10)Å b=13.0861(2)Å c=18.5373(3)Å
α=90.00° β=105.6400(10)° γ=90.00°
2-(4-Bromophenyl)-<i>N</i>-(5-methylpyridin-2-yl)acetamide
C14H13BrN2O
Acta Crystallographica Section E (2012) 68, 8 o2526
a=14.0086(16)Å b=9.4215(11)Å c=20.610(2)Å
α=90.00° β=109.040(2)° γ=90.00°
1-(3-Chlorophenyl)thiourea
C7H7ClN2S
Acta Crystallographica Section E (2012) 68, 8 o2423
a=5.4406(3)Å b=8.5715(4)Å c=9.2392(4)Å
α=104.221(2)° β=91.776(2)° γ=96.362(2)°
1-(2,4-Difluorophenyl)thiourea
C7H6F2N2S
Acta Crystallographica Section E (2012) 68, 8 o2460
a=6.4260(7)Å b=36.908(4)Å c=6.6821(7)Å
α=90.00° β=100.464(2)° γ=90.00°
2-(2-Fluorophenyl)-<i>N</i>-(1,3-thiazol-2-yl)acetamide
C11H9FN2OS
Acta Crystallographica Section E (2012) 68, 8 o2565
a=11.9043(13)Å b=5.2969(6)Å c=16.4579(18)Å
α=90.00° β=90.397(3)° γ=90.00°
2-(4-Bromophenyl)-<i>N</i>-(3-chloro-4-fluorophenyl)acetamide
C14H10BrClFNO
Acta Crystallographica Section E (2012) 68, 8 o2558
a=4.9120(5)Å b=6.3131(6)Å c=42.517(4)Å
α=90.00° β=90.00° γ=90.00°
<i>N</i>-(4-Chlorophenyl)-2,2-diphenylacetamide
C20H16ClNO
Acta Crystallographica Section E (2012) 68, 8 o2556-o2557
a=10.2147(2)Å b=17.8203(4)Å c=9.5730(2)Å
α=90.00° β=114.0190(10)° γ=90.00°
(2<i>E</i>)-3-(2-Fluorophenyl)-1-(4-fluorophenyl)prop-2-en-1-one
C15H10F2O
Acta Crystallographica Section E (2012) 68, 9 o2658
a=14.569(2)Å b=7.2737(10)Å c=11.3933(15)Å
α=90.00° β=108.827(3)° γ=90.00°
<i>N</i>-(2-Bromophenyl)-2-(naphthalen-1-yl)acetamide
C18H14BrNO
Acta Crystallographica Section E (2012) 68, 9 o2657
a=4.76030(10)Å b=11.4614(3)Å c=26.6255(6)Å
α=90.00° β=90.00° γ=90.00°
2,2-Diphenyl-<i>N</i>-(2,4,5-trichlorophenyl)acetamide
C20H14Cl3NO
Acta Crystallographica Section E (2012) 68, 9 o2659-o2660
a=18.6630(16)Å b=17.1713(15)Å c=22.5648(19)Å
α=90.00° β=90.00° γ=90.00°
2-(4-Chlorophenyl)-<i>N</i>-(1,3-thiazol-2-yl)acetamide
C11H9ClN2OS
Acta Crystallographica Section E (2012) 68, 9 o2679
a=13.9169(13)Å b=5.5188(5)Å c=15.1836(14)Å
α=90.00° β=100.311(2)° γ=90.00°
2-(4-Bromophenyl)-<i>N</i>-(2,6-dimethylphenyl)acetamide
C16H16BrNO
Acta Crystallographica Section E (2012) 68, 9 o2678
a=4.7146(6)Å b=22.999(3)Å c=13.5350(15)Å
α=90.00° β=91.138(3)° γ=90.00°
<i>N</i>-(1,5-Dimethyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazol-4-yl)- 2-[4-(methylsulfanyl)phenyl]acetamide
C20H21N3O2S
Acta Crystallographica Section E (2012) 68, 9 o2677
a=14.9176(8)Å b=6.6527(4)Å c=19.5792(10)Å
α=90.00° β=110.6890(10)° γ=90.00°
(2<i>E</i>)-3-[4-(Benzyloxy)phenyl]-1-(pyridin-3-yl)prop-2-en-1-one
C21H17NO2
Acta Crystallographica Section E (2012) 68, 9 o2724
a=5.9845(6)Å b=38.187(4)Å c=8.5412(7)Å
α=90.00° β=123.372(5)° γ=90.00°
1,1'-[2,4-Bis(3-nitrophenyl)cyclobutane-1,3-diyl]diphenylmethanone
C30H22N2O6
Acta Crystallographica Section E (2012) 68, 12 o3272-o3273
a=5.78500(10)Å b=14.7824(3)Å c=14.3589(3)Å
α=90.00° β=104.8580(10)° γ=90.00°
2-(3,4-Dichlorophenyl)-<i>N</i>-(1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro- 1<i>H</i>-pyrazol-4-yl)acetamide
C19H17Cl2N3O2
Acta Crystallographica Section E (2013) 69, 3 o402-o403
a=17.2064(8)Å b=20.7984(9)Å c=15.6102(7)Å
α=90.00° β=101.213(4)° γ=90.00°
2-(2,6-Dichlorophenyl)-<i>N</i>-(1,3-thiazol-2-yl)acetamide
C11H8Cl2N2OS
Acta Crystallographica Section E (2013) 69, 4 o523
a=7.1278(4)Å b=8.4434(4)Å c=10.3637(6)Å
α=95.341(4)° β=106.140(5)° γ=96.745(4)°
2-(3,4-Dichlorophenyl)-<i>N</i>-(1,3-thiazol-2-yl)acetamide
C11H8Cl2N2OS
Acta Crystallographica Section E (2013) 69, 5 o645-o646
a=4.6185(3)Å b=7.7741(7)Å c=17.1188(12)Å
α=100.278(7)° β=94.250(6)° γ=105.001(7)°
2-(2,4-Dichlorophenyl)-<i>N</i>-(1,3-thiazol-2-yl)acetamide
C11H8Cl2N2OS
Acta Crystallographica Section E (2013) 69, 5 o656-o657
a=5.3262(2)Å b=10.5083(4)Å c=10.8096(4)Å
α=83.900(3)° β=86.301(3)° γ=87.279(4)°
4-(3-Fluoro-4-methylanilino)-2-methylidene-4-oxobutanoic acid
C12H12FNO3
Acta Crystallographica Section E (2013) 69, 12 o1752
a=6.3368(3)Å b=8.2642(4)Å c=21.0277(11)Å
α=84.057(4)° β=89.798(4)° γ=86.062(4)°
<i>N</i>-(4-Bromo-3-methylphenyl)-2-phenylacetamide
C15H14BrNO
Acta crystallographica. Section C, Structural chemistry (2014) 70, Pt 9 889-894
a=4.9995(3)Å b=10.8392(4)Å c=12.7301(7)Å
α=108.149(4)° β=91.968(5)° γ=90.310(4)°